The inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.
Artificial intelligence could be used to prescribe medications to patients — if a new bill makes its way through Congress ...
Germany’s Merck KGaA is in advanced talks for a potential acquisition of SpringWorks Therapeutics, a U.S. biopharmaceutical ...
After a slow 2024, dealmaking in the U.S. healthcare sector is picking up. Springworks has a market value of $3 billion.
Merck KGaA said it’s in advanced talks to purchase SpringWorks Therapeutics Inc., sending shares of the US cancer and rare ...
The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback